Abstract
Endometrial intraepithelial neoplasia (EIN), also known as endometrial atypical hyperplasia (EAH) is believed to be the precursor lesion of endometrioid endometrial carcinoma (EEC). Many genetic factors play important roles in the process of carcinogenesis, however, the key genetic alterations from dysplasia to endometrial cancer remains poorly understood. Germline mutations in Lynch syndrome genes are associated with hereditary endometrial carcinoma. The role of other cancer susceptibility genes is unclear. The aim of this study was to investigate the genomic alterations of premalignant endometrial lesion and EEC, and to determine the prevalence of cancer predisposition gene mutations in an unselected endometrial carcinoma patient cohort. Here, we applied a comprehensive cancer gene panel (363 cancer-related genes) to capture the exomes of cancer-related genes. Samples were collected from 79 patients with EEC and 36 patients with EIN. Our results demonstrate that EIN harbors most of the driver events reported in EEC and for the first time we reported a high frequency of the amplification of VEGFB gene in endometrial cancer. Moreover, we identified four novel candidate cancer-associated genes (CTCF, ARHGAP35, NF1, and KDR) which may be crucial in the carcinogenesis of EEC. In addition, we identified 2 patients who had a deleterious germline mutation in Lynch syndrome genes (MLH1 and MLH2), and another 8 patients harbored germline mutations of 6 non-Lynch syndrome genes (MUTYH, GALNT12, POLE, MPL, ATM, and ERCC4) which may be associated with endometrial cancer. Larger series will have to be investigated to assess the risks and the proportion of endometrial cancers attributable to other genes.
Highlights
Endometrial cancer (EC) is the most frequent gynecological cancer in developed countries, globally affecting more than 380,000 new women each year [1]
We identified a total of 1,803 variants in 310 genes, including 1,620 single-nucleotide variants (SNVs) and 183 small scale insertions/deletions (Supplementary Table 2)
We find that 4 cases (11.1%) with Endometrial intraepithelial neoplasia (EIN) and 24 cases (30.4%) with endometrial carcinoma (EEC) have concurrent mutations of PTEN and PIK3CA (P = 0.046)
Summary
Endometrial cancer (EC) is the most frequent gynecological cancer in developed countries, globally affecting more than 380,000 new women each year [1]. With the rapid development of the economy in China, people’s living habits and dietary structure have undergone great changes. In China, endometrial cancer ranks second among gynecological cancers in its incidence, with approximately 63,400 new cases diagnosed in 2015 [2]. 80% of all endometrial carcinomas are of endometrioid endometrial carcinoma (EEC), which are associated with long stimulation of estrogen without antagonism of progestogen and have a favorable prognosis [3]. The genetic landscape of EEC has been characterized in 2013 by TCGA, which reveals frequent mutations in PTEN, CTNNB1, PIK3CA, ARID1A, KRAS, and novel mutations in the SWI/SNF chromatin remodeling complex gene ARID5B [4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
